Mohnark Pharmaceuticals is recalling approximately 9,000 units of its Lidocaine 4% Topical Anesthetic Cream because the packaging is not child-resistant. The product contains lidocaine (lidocaine 4% w/w), which is required to have child-resistant packaging under the Poison Prevention Packaging Act (PPPA). Without this safety feature, young children can easily open the tube and ingest the cream, which poses a serious poisoning risk. The recalled cream was sold in 30 g white tubes at Amazon.com and Walmart.com between January 2021 and January 2022.
The packaging is not child-resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream. No incidents or injuries have been reported to date.
Consumers should immediately stop using the recalled cream and store it in a location out of sight and reach of children. Contact Mohnark Pharmaceuticals for instructions on how to dispose of the product to receive a full refund. Mohnark Pharmaceuticals is contacting all known purchasers directly.
Mohnark Pharmaceuticals logo is blue and green; lot code is located at the bottom of the product tube.
Recalled Mohnark Pharmaceuticals Lidocaine 4% Topical Anesthetic Cream packaging
Recalled Mohnark Pharmaceuticals Lidocaine 4% Topical Anesthetic Cream
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: CPSC Notice · Raw API Response